Skip to main content
. 2015 Jan 22;4(3):e994374. doi: 10.4161/2162402X.2014.994374

Figure 4.

Figure 4.

DC vaccine is required for T cell persistence. (A) In vivo frequency of adoptively transferred antitumor DsRed+ T lymphocytes was measured in lymph nodes one week after ACT without RNA-pulsed DC vaccine or (B) after RNA-pulsed DC vaccine. (C) Enumeration of DsRed+ adoptively transferred T cells in lymph nodes with or without DC vaccination (*p = 0.002, Mann–Whitney test, n = 6).